TAK Stock Price Prediction 2026
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)
AI-powered price predictions based on fundamental analysis and growth projections
- MACD converging near zero line - potential energy building
- Volume showing accumulation (CMF: 0.4513)
- Recent pattern: Doji - Indecision pattern
- Price near resistance at $17.17
Based on PEG ratio analysis, this stock appears overvalued at current levels. Consider waiting for a better entry point or reassess fundamentals.
Volume Trend: Accumulation
Institutional Buying Detected - Smart money is accumulating shares
Positive CMF indicates money flowing into the stock. This bullish signal suggests institutional interest.
| Timeframe | Target Price | Potential Return |
|---|---|---|
| 30 Days | $17.28 | +0.3% |
| 90 Days | $17.39 | +1.0% |
| 6 Months | $17.56 | +1.9% |
| 1 Year | $17.89 | +3.8% |
| 2 Years EXTENDED | $18.64 | +8.2% |
| 3 Years EXTENDED | $19.43 | +12.8% |
More TAK Analysis
Scenario Analysis (1-Year Outlook)
Best case scenario if strong fundamentals and market conditions align
Expected scenario based on current growth trajectory
Downside scenario if market headwinds or disappointing results